Literature DB >> 9358744

Mice lacking the thrombin receptor, PAR1, have normal skin wound healing.

A J Connolly1, D Y Suh, T K Hunt, S R Coughlin.   

Abstract

Thrombin's actions on platelets, macrophages, fibroblasts, and endothelial cells have prompted the hypothesis that thrombin may be important for inflammatory and fibroproliferative processes in wound healing. Protease-activated receptor 1 (PAR1) is a G-protein-coupled receptor that mediates many of the cellular activities of thrombin. To test the role of this receptor in vivo, we generated PAR1-deficient mice. Despite the observation that fibroblasts cultured from these mice lacked responsiveness to thrombin in vitro, we now report that there was no difference detected between wild-type and PAR1-deficient mice in skin wound healing assays including time to closure of open wounds, tensile strength of healed incisional wounds, wound histology, and hydroxyproline/DNA content of wound implants. We conclude that PAR1 is not necessary for normal skin wound healing in mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358744      PMCID: PMC1858088     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Determination of the tensile strength of the healing wound as a clinical test.

Authors:  P SANDBLOM; P PETERSEN; A MUREN
Journal:  Acta Chir Scand       Date:  1953

2.  Examination of expanded polytetrafluoroethylene wound healing models.

Authors:  C Wicke; B J Halliday; H Scheuenstuhl; E F Foree; T K Hunt
Journal:  Wound Repair Regen       Date:  1995 Jul-Sep       Impact factor: 3.617

3.  Domains specifying thrombin-receptor interaction.

Authors:  T K Vu; V I Wheaton; D T Hung; I Charo; S R Coughlin
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

4.  Molecular cloning of a potential proteinase activated receptor.

Authors:  S Nystedt; K Emilsson; C Wahlestedt; J Sundelin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

5.  Selective immobilization of alpha-thrombin by surface-bound fibrin.

Authors:  G D Wilner; M P Danitz; M S Mudd; K H Hsieh; J W Fenton
Journal:  J Lab Clin Med       Date:  1981-03

6.  Protease-activated receptor 3 is a second thrombin receptor in humans.

Authors:  H Ishihara; A J Connolly; D Zeng; M L Kahn; Y W Zheng; C Timmons; T Tram; S R Coughlin
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

7.  Ligand cross-reactivity within the protease-activated receptor family.

Authors:  B D Blackhart; K Emilsson; D Nguyen; W Teng; A J Martelli; S Nystedt; J Sundelin; R M Scarborough
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

8.  Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode.

Authors:  J Chen; M Ishii; L Wang; K Ishii; S R Coughlin
Journal:  J Biol Chem       Date:  1994-06-10       Impact factor: 5.157

9.  Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin.

Authors:  F Colotta; F L Sciacca; M Sironi; W Luini; M J Rabiet; A Mantovani
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

10.  Thrombin stimulates neutrophil adherence by an endothelial cell-dependent mechanism: characterization of the response and relationship to platelet-activating factor synthesis.

Authors:  G A Zimmerman; T M McIntyre; S M Prescott
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

View more
  17 in total

Review 1.  Wound healing in hemophilia B mice and low tissue factor mice.

Authors:  Dougald M Monroe; Nigel Mackman; Maureane Hoffman
Journal:  Thromb Res       Date:  2010-02-19       Impact factor: 3.944

2.  Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury.

Authors:  James P Luyendyk; Nigel Mackman; Bradley P Sullivan
Journal:  Toxicol Sci       Date:  2010-10-25       Impact factor: 4.849

3.  Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.

Authors:  Patricia Redecha; Claus-Werner Franzke; Wolfram Ruf; Nigel Mackman; Guillermina Girardi
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

4.  Expression of thrombomodulin and consequences of thrombomodulin deficiency during healing of cutaneous wounds.

Authors:  J J Peterson; H B Rayburn; D J Lager; T J Raife; G P Kealey; R D Rosenberg; S R Lentz
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet.

Authors:  Karen M Kassel; A Phillip Owens; Cheryl E Rockwell; Bradley P Sullivan; Ruipeng Wang; Ossama Tawfik; Guodong Li; Grace L Guo; Nigel Mackman; James P Luyendyk
Journal:  Am J Pathol       Date:  2011-09-09       Impact factor: 4.307

6.  Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain.

Authors:  G C Parry; N Mackman
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice.

Authors:  James P Luyendyk; Bradley P Sullivan; Grace L Guo; Ruipeng Wang
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  Protease activated receptors in cardiovascular function and disease.

Authors:  Junor A Barnes; Shamjeet Singh; Aldrin V Gomes
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

Review 9.  Wound-healing studies in transgenic and knockout mice.

Authors:  Richard Grose; Sabine Werner
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

10.  From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis.

Authors:  Rance Nault; Kelly A Fader; Anna K Kopec; Jack R Harkema; Timothy R Zacharewski; James P Luyendyk
Journal:  Toxicol Sci       Date:  2016-09-09       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.